EU/3/19/2204

Table of contents

About

On 17 October 2019, orphan designation EU/3/19/2204 was granted by the European Commission to Voisin Consulting S.A.R.L., France, for 18-(p-(131I)-iodophenyl)octadecyl phosphocholine (also known CLR 131) for the treatment of multiple myeloma.

Key facts

Active substance
18-(p-(131I)-iodophenyl)octadecyl phosphocholine
Disease / condition
Treatment of multiple myeloma
Date of first decision
17/10/2019
Outcome
Positive
EU designation number
EU/3/19/2204

Sponsor's contact details

Voisin Consulting S.A.R.L.
64 Avenue Pierre Grenier
92100 Boulogne Billancourt
France
Tel: +33 1 41 31 63 64
E-mail: orphan@voisinconsulting.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

How useful was this page?

Add your rating